Here's some information that pins down the nicotine content of transdermal patches and which details the known or potential ingredients of the various product brands. I would imagine a great place to start would be in determining the solubility of the various compounds in the solvent you intend to use and then to assess the potential success of separation using filtration techniques taking into account the various binding properties. Barring that I imagine one would at least want to research the potential toxic effects of the inhalation of any of the ingredients which, in addition to nicotine, might be left over if there isn't any certain method of removing them.
What form(s) does Nicoderm come in?
21 mg/day
Each rectangular 22 cm² system contains nicotine 114 mg and provides 24-hour rate-controlled delivery of 21 mg/day to the patient. Nonmedicinal ingredients: ethylene vinyl acetate copolymer, polyisobutylene and high density polyethylene between polyester backings.
Walgreens Stop Smoking Aid Step 1 - 21 mg, Patches
Ingredients: Acrylate Adhesive , Aluminized Polyester , Cellulose Paper, Methacrylic Acid Copolymer
Equate: Stop Smoking Aid Patch Nicotine Transdermal System, 21 mg
Ingredients
Active Ingredients: Nicotine. Inactive Ingredients: Acrylate Adhesive, Aluminized Polyester, Cellulose Paper, Methacrylic Acid Copolymer.
Novartis Nicotine Transdermal System Patch 21 mg Step 1- 7 Patches
INGREDIENTS
Active Ingredients
er Patch: Nicotine 21 mg Delivered Over 24 Hours.
Inactive Ingredients:Acrylate Adhesive; Aluminized Polyester; Cellulose Paper; Methacrylic Acid Copolymer.
Nicotine is well suited for transepidermal delivery because it is a liquid which is known to penetrate skin easily. In fact, there are documented cases of
tobacco workers suffering from nicotine overdose as a result of handling raw
tobacco leaves, a condition known as Green
tobacco Sickness. Depending on the type of patch, the amount of nicotine compound employed varies between 5% and 50%. The drug may be used in its pure form, or it may be linked with other chemicals entities such as hydrochloride, dihydrochloride, sulfate, tartrate, bitartarate, zinc chloride, and salicylate to form derivatives.
When preparing patches with these chemicals, there are two key areas of concern. The first is dosage, since too high a dose can cause irregular heartbeat, palpitations, nausea, vomiting, dizziness, or weakness. In fact, 60 mg of nicotine (the equivalent of smoking 60 cigarettes at once) is considered to be a lethal dose. Therefore, it is critical that the patch be calibrated to deliver the prescribed amount. The second consideration is related to the solvent properties of nicotine. The drug will attack or dissolve many of the materials used to make patch components. Many adhesives, for example, become stringy and loose their tackiness when exposed to nicotine. Or, they may become so heavily loaded with the drug that they deliver an unacceptably large burst of nicotine when attached to the skin. The compatibility of all patch materials that contact nicotine must be carefully evaluated.
Delivery vehicle
The patch itself is a small disk approximately 1 in (2.5 cm) or less in diameter, which may be assembled in several different configurations. One type of patch consists of a plastic chamber that contains the drug and is covered by a selectively permeable membrane to control the rate at which the drug is delivered. This carrier layer can be made from a variety of plastics, including polyvinyl chloride, polystyrene, polyurethane, ethylene vinyl acetate, polyester, polyolefin, and polycarbonate. Alternately, the carrier may be of the matrix type, also known as the monolith type. In this configuration, the drug is dispersed or suspended in the solid plastic matrix of the carrier. In yet another patch design, the drug is mixed directly with the adhesive and applied to a plastic support layer. Regardless of which patch design is employed, the disk must deliver the drug at a controlled rate. It is also important that the device be made from a plastic material which is flexible enough to be applied and removed from skin without breaking or tearing.
Backing layer
All patch configurations feature an occlusive backing layer that is impermeable to the drug. This is typically a plastic sheet laminated with metallic foil to increase its barrier properties and prevent the drug from leaking.
Adhesive
The adhesive used to mount the patch on the skin is extremely important. There are a number of medical grade, pressure-sensitive adhesives, such as acrylate ester/vinyl pyrrolidone copolymers, dimethyl silicone polymers, and acrylate polymers. The latter dominate medical adhesive market, mainly because of their low level of allergenicity. In addition to being nonirritating to the skin, a patch adhesive must have good water resistance so it continues to adhere when the skin perspires. It must have sufficiently high cohesive strength to allow clean removal of adhesive from skin, and it must have properties that allow it to accommodate skin movement without losing the bond and without excessive skin irritation. As described above, care must be taken to ensure the adhesive will not degrade after prolonged contact with nicotine.
Other ingredients
Other ingredients, such as pigments, dyes, inert fillers, and processing aids, may be mixed in with the drug. Certain types of patches also include permeation enhancers to improve drug penetration. For example, one manufacturer of transepidermal patches includes low levels of alcohol to enhance skin penetration. Some nicotine patches contain antipruritic (anti-itch) agents to treat the pruritus associated with transdermal delivery of nicotine. These antipruritic drugs are selected from a group consisting of bisabolol, oil of chamomile, chamazulene, allantoin, D-panthenol, glycyrrhetenic acid, corticosteroids, and antihistamines.